Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

SRx Health Solutions (SRXH) Shares Outstanding (2016 - 2025)

SRx Health Solutions' Shares Outstanding history spans 15 years, with the latest figure at $24.9 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 10.76% year-over-year to $24.9 million; the TTM value through Sep 2025 reached $24.9 million, up 10.76%, while the annual FY2025 figure was $24.9 million, N/A changed from the prior year.
  • Shares Outstanding reached $24.9 million in Q3 2025 per SRXH's latest filing, up from $15.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $29.4 million in Q1 2022 to a low of $17306.0 in Q1 2021.
  • Average Shares Outstanding over 5 years is $12.5 million, with a median of $8.8 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding: crashed 99.79% in 2021, then soared 169579.37% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $662417.0 in 2021, then increased by 0.97% to $668869.0 in 2022, then grew by 8.99% to $729026.0 in 2023, then skyrocketed by 3198.67% to $24.0 million in 2024, then grew by 3.61% to $24.9 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Shares Outstanding are $24.9 million (Q3 2025), $15.2 million (Q2 2025), and $2.5 million (Q1 2025).